PRFX - PainReform Quarterly EPS earnings growth
The innovative non-opioid extended-release pain management technology from PainReform Ltd. (PRFX) supports current momentum, where the quarterly EPS growth rate visualizes the pace of development. The current level of -3.60 reflects the state of the profit parameter. Prospects depend on the PRF-110 system patents and hospital expansion, although risks of FDA delays and commercialization costs for the PLFE drug remain.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_PRFX_-_PainReform-Ltd._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "painreform.com (PRFX): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/11/2026 | 👁️GURU.Markets👁️")
PRFX (PainReform Corp): analytical breakdowns and indicator data
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital PainReform Ltd.|PRFX - Long-Term Debt to Capital|Short-Term Debt to Capital PainReform Ltd.|PRFX - Company Total Debt Obligations|Debt to Book Capitalization Ratio PainReform Limited|PRFX - Company Long-Term Indebtedness|Company Short-Term Debt PainReform|Quick Ratio painreform.com
- earnings and market multiples details:
PRFX - Company Net Income|Projected Future Earnings PainReform Ltd.|PRFX - Market Cap to Net Income|Future Price to Earnings PainReform Limited|PRFX - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PainReform Limited|PRFX - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months PainReform|PRFX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months painreform.com|PRFX - Earnings per share increase in current year|Net earnings per share growth forecast for next year PainReform Ltd.
Analysis of all company metrics:PainReform Ltd.
Investors assess capital risks through net income dynamics, which reflect the actual efficiency of resource management. For PainReform Ltd. (PRFX), which is scaling anesthetic formulations to meet FDA requirements, comparing quarterly EPS measures the rate of change in earnings per share, allowing for the identification of how operating expenses impact final returns and determining the sustainability of the business model during the clinical trial period.
Key competitors
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|ALVO (Alvotech S.A.) - Year-over-year net earnings per share trend for the last twelve months|Liquidia Technologies - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|MNKD - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amphastar Pharmaceuticals, Inc.|Year-over-year earnings per share growth for the last 12 months PCRX (Pacira Pharmaceuticals)|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|TBPH (Theravance Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|scPharmaceuticals, Inc. (SCPH) - Earnings per share growth in annualized terms for the last twelve months|Tectonic - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|sxtchina.com (SXTC) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Eupraxia Pharmaceuticals Inc. (EPRX)|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Oramed Pharmaceuticals (ORMP)|Year-over-year net earnings per share growth for the last 12 months enterabio.com ENTX|MindWalk - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|QNTM: Year-over-year earnings per share growth for the last twelve months|FGEN (FibroGen) - Year-over-year net earnings per share growth for the last 12 months|TELO: Year-over-year earnings per share growth rate for the last twelve months|RANI (Rani Therapeutics Holdings) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months SNYR (Synergy CHC Corporation)|Year-over-year net earnings per share growth for the last 12 months RLYB (Rallybio Corporation)|Year-over-year net earnings per share change for the last twelve months lexariabioscience.com|Year-over-year earnings per share growth for the last twelve months Pulmatrix PULM|PTHL (Pheton Holdings Limited) - Year-over-year net earnings per share trend for the last twelve months|APM - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months LYRA (Lyra Therapeutics Inc)|IBO: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNFA (TNF Pharmaceuticals, Inc.)|Year-over-year net earnings per share growth for the last 12 months YCBD|Year-over-year earnings per share growth for the last 12 months CYTO (Auris Medical)|Year-over-year earnings per share growth for the last twelve months Lipella (LIPO)|OPTN: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth PIRS (Pieris Pharmaceuticals)|Year-over-year earnings per one share growth for the last 12 months PROC|Petros Pharmaceuticals, Inc. - Quarterly EPS earnings growth|QLI - Quarterly EPS earnings growth|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|TFF Pharmaceuticals, Inc - Year-over-year earnings per one share growth for the last 12 months
